Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
This work was supported by the Burroughs Wellcome Fund Vanderbilt SCRIPS Faculty Scholar Award (PI: Naira Baregamian) and the National Cancer Institute/Vanderbilt-Ingram Cancer Center Multi-Tier Developmental Support Grant (P30CA068485) (PI: Naira Baregamian)
50 mg 30 capsules $200 Supports mitochondrial function and cellular energy production, studied for its potential role in healthy aging and metabolic balance
* Based on the trial product estimand: estimated efficacy in an idealized scenario in which all patients stayed on treatment and took no other weight loss therapies ** Based on the treatment policy estimand: estimated efficacy regardless of whether patients stayed on treatment or took other weight loss therapies About CagriSema CagriSema is being investigated by Novo Nordisk as a once-weekly subcutaneous injectable treatment for adults with overweight or obesity (REDEFINE program) and as a treatment for adults with type 2 diabetes (REIMAGINE program)
Small human studies have reported increases in glutathione measurements and selected oxidative-stress or immune markers following use of a tested liposomal formulation
US$ 22.24
US$ 21.76
US$ 28.93
US$ 29.55
US$ 20.56
US$ 29.76
US$ 20.93
